The NIHR Global Health Research Unit on Global Surgery
Improving surgical outcomes through collaborative research
CovidSurg is a platform of studies aiming to explore the impact of COVID-19 in surgical patients and services. Our studies are designed and delivered by an international collaborating group of surgeons and anaesthetists which reached more than 80 countries.
COVIDSURG
Improving surgical outcomes through collaborative research
Patients diagnosed with COVID-19 who need surgery are a challenging group. Capturing real-world data and sharing international experience will inform the management of this complex group of patients who undergo surgery throughout the COVID-19 pandemic, improving their clinical care.
Primary aim
- To determine 30-day mortality in patients with COVID-19 infection who undergo surgery. This will inform future risk stratification, decision making, and patient consent.
COVIDSURG - CANCER
Improving surgical outcomes through collaborative research
Any centre performing elective cancer surgery affected by COVID-19 could participate in this study. Investigators could choose one or more cancer types from their centre from which to upload data. This study could be performed prospectively, retrospectively or using a mixed model, dependent on the phase of COVID-19 infection in that team’s hospital.
Primary aim
- To evaluate the 30-day postoperative pulmonary complication rate following elective cancer surgery during the COVID-19 pandemic.
COVIDSURG WEEK
Improving surgical outcomes through collaborative research
CovidSurg Week is an international multi-centre prospective cohort study in which patients from all specialities undergoing a surgical procedure done in an operating theatre could be included (any SARS-CoV 2 status).
Primary aim
- To determine the optimal timing for surgery following SARS-CoV-2 infection.
COVIDSURG 3 - OMICRON
Improving surgical outcomes through collaborative research
With the emergence of the Omicron SARS-CoV-2 variant of concern, there is currently little evidence regarding disease severity in both vaccinated and unvaccinated patients (including in surgical patients), nor is there data to guide patient risk stratification during Omicron COVID-19 waves.
This new study aims to provide renewed rapid data to guide global practice during Omicron COVID-19 waves.
CovidSurg-3 has two separate components:
- Patient-level component: Collection of outcome data for patients with peri-operative SARS-CoV-2.
- Hospital-level component: Collection of aggregated case-mix data. Hospitals in countries with low community SARS-CoV-2 infection rates can contribute towards this component.
Primary aim
- To determine 30-day mortality in patients with peri-operative SARS-CoV-2 infection. This will inform future risk stratification, decision making, and patient consent.
" Bringing together surgeons, researchers and policy makers to set the local research agenda according to patient need in LMIC and ensuring all patients have the opportunity to take part in our research. "